Drugs / Taodan Granules

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03942198 Jun 2019 → Dec 2021 psoriasis Shanghai Yueyang Integrated Medicine Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Taodan Granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT03942198 ↗
Known as TDKL “patients with psoriasis with blood-stasis syndrome treated with Taodan granules (TDKL).” PMID 31700924 ↗ Sep 2019